BUPROPION VERSUS METHYLPHENIDATE IN THE TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER
Uloženo v:
BARRICKMAN, L.L., ET AL., BUPROPION VERSUS METHYLPHENIDATE IN THE TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, Vol. 34, no. 5 (1995), p. 649-657.
Ref.
49293
Umístění:
SIIS SIIS Madrid R.598
Palabras clave:
Enfermedades mentales, Fármacos, Hiperactividad, Infancia, Trastornos de atención, Tratamiento
Enfermedades mentales, Fármacos, Hiperactividad, Infancia, Trastornos de atención, Tratamiento
Podobné jednotky: BUPROPION VERSUS METHYLPHENIDATE IN THE TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER
- BUPROPION HYDROCHLORIDE IN ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY
- METHYLPHENIDATE TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER IN BOYS WITH TOURETTE'S SYNDROME
- PREDICTION OF CLINICAL RESPONSE TO METHYLPHENIDATE IN CHILDREN WITH ATTENTION-DEFICIT HYPERACTIVITY DISORDER
- BUPROPION TREATMENT FOR COCAINE ABUSE AND ADULT ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
- A DIVIDED ATTENTION ANALYSIS OF THE EFFECTS OF METHYLPHENIDATE ON THE ARITHMETIC PERFORMANCE OF CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER
- MEGADOSE INTRANASAL METHYLPHENIDATE (RITALIN) ABUSE IN ADULT ATTENTION DEFICIT HYPERACTIVITY DISORDER